Show simple item record

Evolutionary foundations for cancer biology

dc.contributor.authorAktipis, C. Athenaen_US
dc.contributor.authorNesse, Randolph M.en_US
dc.date.accessioned2013-02-12T19:00:15Z
dc.date.available2014-03-03T15:09:23Zen_US
dc.date.issued2013-01en_US
dc.identifier.citationAktipis, C. Athena; Nesse, Randolph M. (2013). "Evolutionary foundations for cancer biology." Evolutionary Applications (1): 144-159. <http://hdl.handle.net/2027.42/96232>en_US
dc.identifier.issn1752-4571en_US
dc.identifier.issn1752-4571en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/96232
dc.description.abstractNew applications of evolutionary biology are transforming our understanding of cancer. The articles in this special issue provide many specific examples, such as microorganisms inducing cancers, the significance of within‐tumor heterogeneity, and the possibility that lower dose chemotherapy may sometimes promote longer survival. Underlying these specific advances is a large‐scale transformation, as cancer research incorporates evolutionary methods into its toolkit, and asks new evolutionary questions about why we are vulnerable to cancer. Evolution explains why cancer exists at all, how neoplasms grow, why cancer is remarkably rare, and why it occurs despite powerful cancer suppression mechanisms. Cancer exists because of somatic selection; mutations in somatic cells result in some dividing faster than others, in some cases generating neoplasms. Neoplasms grow, or do not, in complex cellular ecosystems. Cancer is relatively rare because of natural selection; our genomes were derived disproportionally from individuals with effective mechanisms for suppressing cancer. Cancer occurs nonetheless for the same six evolutionary reasons that explain why we remain vulnerable to other diseases. These four principles—cancers evolve by somatic selection, neoplasms grow in complex ecosystems, natural selection has shaped powerful cancer defenses, and the limitations of those defenses have evolutionary explanations—provide a foundation for understanding, preventing, and treating cancer.en_US
dc.publisherSinauer Associatesen_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherEvolutionary Medicineen_US
dc.subject.otherMismatchen_US
dc.subject.otherNeoplasticen_US
dc.subject.otherVulnerabilityen_US
dc.subject.otherEcologicalen_US
dc.subject.otherDarwinianen_US
dc.titleEvolutionary foundations for cancer biologyen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelEcology and Evolutionary Biologyen_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid23396885en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/96232/1/eva12034.pdf
dc.identifier.doi10.1111/eva.12034en_US
dc.identifier.sourceEvolutionary Applicationsen_US
dc.identifier.citedreferenceNowell, P. C. 1976. The clonal evolution of tumor cell populations. Science 194: 23 – 28.en_US
dc.identifier.citedreferenceShen, X. J., J. F. Rawls, T. Randall, L. Burcal, C. N. Mpande, N. Jenkins, B. Jovov et al. 2010. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 1: 138 – 147. doi: 10.4161/gmic.1.3.12360.en_US
dc.identifier.citedreferenceSmith, K. R., H. A. Hanson, G. P. Mineau, and S. S. Buys. 2011. Effects of BRCA1 and BRCA2 mutations on female fertility. Proceedings. Biological Sciences/The Royal Society. doi: 10.1098/rspb.2011.1697.en_US
dc.identifier.citedreferenceSprouffske, K., C. A. Aktipis, J. P. Radich, M. Carroll, A. M. Nedelcu, and C. C. Maley this issue. An evolutionary explanation for the presence of cancer non‐stem cells in neoplasms. Evolutionary Applications In this issue.en_US
dc.identifier.citedreferenceSrivastava, A., J. L. Hornick, X. Li, P. L. Blount, C. A. Sanchez, D. S. Cowan, K. Ayub et al. 2007. Extent of low‐grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus. The American Journal of Gastroenterology 102: 483 – 493. quiz 694. doi: 10.1111/j.1572‐0241.2007.01073.x.en_US
dc.identifier.citedreferenceStanton, S. J., and O. C. Schultheiss. 2007. Basal and dynamic relationships between implicit power motivation and estradiol in women. Hormones and behavior 52: 571 – 580. doi: 10.1016/j.yhbeh.2007.07.002.en_US
dc.identifier.citedreferenceStearns, S. C.. 2000. Life history evolution: successes, limitations, and prospects. Die Naturwissenschaften 87: 476 – 486.en_US
dc.identifier.citedreferenceStearns, S. C., and J. C. Koella. 2008. Evolution in Health and Disease, Oxford University Press, USA.en_US
dc.identifier.citedreferenceStephens, P. J., C. D. Greenman, B. Fu, F. Yang, G. R. Bignell, L. J. Mudie, E. D. Pleasance, et al. 2011. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144: 27 – 40. doi: 10.1016/j.cell.2010.11.055.en_US
dc.identifier.citedreferenceStrassmann, B. I.. 1999. Menstrual cycling and breast cancer: an evolutionary perspective. Journal of Women's Health/The Official Publication of the Society for the Advancement of Women's Health Research 8: 193 – 202.en_US
dc.identifier.citedreferenceTakubo, K., J. M. Nixon, and J. R. Jass. 1995. Ducts of esophageal glands proper and paneth cells in Barrett's esophagus: frequency in biopsy specimens. Pathology 27: 315 – 317.en_US
dc.identifier.citedreferenceThomas, F., D. Fisher, P. Fort, J.‐P. Marie, S. Daust, B. Roche, and C. Grunau, et al. this issue. Applying ecological and evolutionary theory to cancer: A long and winding road. Evolutionary Applications In this issue.en_US
dc.identifier.citedreferenceTomlinson, M., L. Swartz, L. M. Kruger, and O. Gureje. 2007. Manifestations of affective disturbance in sub‐Saharan Africa: key themes. Journal of affective disorders 102: 191 – 198. doi: 10.1016/j.jad.2006.09.029.en_US
dc.identifier.citedreferenceTooby, J. 2011. Cancer as the product of two host‐parasite coevolutionary races. First International Biannual Evolution and Cancer Conference. June. 3 – 5. University of California, San Francisco.en_US
dc.identifier.citedreferenceTyner, S. D., S. Venkatachalam, J. Choi, S. Jones, N. Ghebranious, H. Igelmann, X. Lu, et al. 2002. p53 mutant mice that display early ageing‐associated phenotypes. Nature 415: 45 – 53. doi: 10.1038/415045a.en_US
dc.identifier.citedreferenceVan den Abbeele, P., S. Roos, V. Eeckhaut, D. A. MacKenzie, M. Derde, W. Verstraete, M. Marzorati et al. 2012. Incorporating a mucosal environment in a dynamic gut model results in a more representative colonization by lactobacilli. Microbial biotechnology 5: 106 – 115. doi: 10.1111/j.1751‐7915.2011.00308.x.en_US
dc.identifier.citedreferencede Visser, K. E., A. Eichten, and L. M. Coussens. 2006. Paradoxical roles of the immune system during cancer development. Nature reviews. Cancer 6: 24 – 37. doi: 10.1038/nrc1782.en_US
dc.identifier.citedreferenceWilliams, G. C., and R. M. Nesse. 1991. The dawn of Darwinian medicine. Quarterly Review of Biology 66: 1 – 22.en_US
dc.identifier.citedreferenceWilliams, P. D.. 2010. Darwinian interventions: taming pathogens through evolutionary ecology. Trends in Parasitology 26: 83 – 92. doi: 10.1016/j.pt.2009.11.009.en_US
dc.identifier.citedreferenceWilliams, J. B., D. Pang, B. Delgado, M. Kocherginsky, M. Tretiakova, T. Krausz, D. Pan et al. 2009. A model of gene‐environment interaction reveals altered mammary gland gene expression and increased tumor growth following social isolation. Cancer prevention research 2: 850 – 861. doi: 10.1158/1940‐6207.CAPR‐08‐0238.en_US
dc.identifier.citedreferenceWolin, K. Y., K. Carson, and G. A. Colditz. 2010. Obesity and cancer. The oncologist 15: 556 – 565. doi: 10.1634/theoncologist.2009‐0285.en_US
dc.identifier.citedreferenceYang, L., X. Lu, C. W. Nossa, F. Francois, R. M. Peek, and Z. Pei. 2009. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology 137: 588 – 597. doi: 10.1053/j.gastro.2009.04.046.en_US
dc.identifier.citedreferenceYu, L. C., J. T. Wang, S. C. Wei, and Y. H. Ni. 2012. Host‐microbial interactions and regulation of intestinal epithelial barrier function: from physiology to pathology. World Journal of Gastrointestinal Pathophysiology 3: 27 – 43. doi: 10.4291/wjgp.v3.i1.27.en_US
dc.identifier.citedreferenceAktipis, C. A., C. C. Maley, and S. L. Neuberg. 2010. Psychological barriers to evolutionary thinking in medicine. Evolution and Medicine Review.en_US
dc.identifier.citedreferenceAktipis, C. A., V. S. Kwan, K. A. Johnson, S. L. Neuberg, and C. C. Maley. 2011. Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research. PLoS ONE 6: e26100. doi: 10.1371/journal.pone.0026100.en_US
dc.identifier.citedreferenceAktipis, C. A., C. C. Maley, and J. W. Pepper. 2012. Dispersal evolution in neoplasms: the role of disregulated metabolism in the evolution of cell motility. Cancer Prevention Research (Philadelphia, Pa.) 5: 266 – 275. doi: 10.1158/1940‐6207.CAPR‐11‐0004.en_US
dc.identifier.citedreferenceAlcock, J. 2009. Animal behavior: an evolutionary approach. 9th ed. Sinauer Associates, Sunderland, Mass.en_US
dc.identifier.citedreferenceAlfarouk, K. O., M. E Ibrahim, R. A. Gatenby, and J. S. Brown this issue. Riparian ecosystems in human cancers. Evolutionary Applications In this issue.en_US
dc.identifier.citedreferenceAlthuis, M. D., J. H. Fergenbaum, M. Garcia‐Closas, L. A. Brinton, M. P. Madigan, and M. E. Sherman. 2004. Etiology of hormone receptor‐defined breast cancer: a systematic review of the literature. Cancer Epidemiology, Biomarkers & Prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 13: 1558 – 1568. doi: 13/10/1558 [pii].en_US
dc.identifier.citedreferenceAmerican Cancer Society. 2012. Cancer Facts & Figures 2012. Atlanta.en_US
dc.identifier.citedreferenceAnderson, K., C. Lutz, F. W. van Delft, C. M. Bateman, Y. Guo, S. M. Colman, H. Kempski et al. 2011. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature 469: 356 – 361. doi: 10.1038/nature09650.en_US
dc.identifier.citedreferenceArchie, E. A., J. Altmann, and S. C. Alberts. 2012. Social status predicts wound healing in wild baboons. Proceedings of the National Academy of Sciences of the United States of America 109: 9017 – 9022. doi: 10.1073/pnas.1206391109.en_US
dc.identifier.citedreferenceArthur, J. C., and C. Jobin. 2011. The struggle within: microbial influences on colorectal cancer. Inflammatory bowel diseases 17: 396 – 409. doi: 10.1002/ibd.21354.en_US
dc.identifier.citedreferenceAxelrod, R., D. E. Axelrod, and K. J. Pienta. 2006. Evolution of cooperation among tumor cells. Proceedings of the National Academy of Sciences of the United States of America 103: 13474 – 13479. doi: 10.1073/pnas.0606053103.en_US
dc.identifier.citedreferenceBauer, K. R., M. Brown, R. D. Cress, C. A. Parise, and V. Caggiano. 2007. Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype: a population‐based study from the California cancer Registry. Cancer 109: 1721 – 1728. doi: 10.1002/cncr.22618.en_US
dc.identifier.citedreferenceBeaber, E. F., V. L. Holt, K. E. Malone, P. L. Porter, J. R. Daling, and C. I. Li. 2008. Reproductive factors, age at maximum height, and risk of three histologic types of breast cancer. Cancer Epidemiology, Biomarkers & Prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 17: 3427 – 3434. doi: 17/12/3427 [pii] 10.1158/1055‐9965.EPI‐08‐0641.en_US
dc.identifier.citedreferenceBeckman, R. A., and L. A. Loeb. 2005. Negative clonal selection in tumor evolution. Genetics 171: 2123 – 2131. doi: 10.1534/genetics.105.040840.en_US
dc.identifier.citedreferenceBissell, M. J., and W. C. Hines. 2011. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression Nature medicine 17: 320 – 329. doi: 10.1038/nm.2328.en_US
dc.identifier.citedreferenceBissell, M. J., and D. Radisky. 2001. Putting tumours in context. Nature reviews. Cancer 1: 46 – 54. doi: 10.1038/35094059.en_US
dc.identifier.citedreferenceBlask, D. E., G. C. Brainard, R. T. Dauchy, J. P. Hanifin, L. K. Davidson, J. A. Krause, L. A. Sauer et al. 2005. Melatonin‐depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer research 65: 11174 – 11184. doi: 10.1158/0008‐5472.CAN‐05‐1945.en_US
dc.identifier.citedreferenceCalistro Alvarado, L. this issue. An Evolutionary Perspective on Population Differences in Men's Testosterone Secretion and Prostate Cancer Disparities. Evolutionary Applications In this issue.en_US
dc.identifier.citedreferenceCampbell, P. J., E. D. Pleasance, P. J. Stephens, E. Dicks, R. Rance, I. Goodhead, G. A. Follows et al. 2008. Subclonal phylogenetic structures in cancer revealed by ultra‐deep sequencing. Proceedings of the National Academy of Sciences of the United States of America 105: 13081 – 13086. doi: 10.1073/pnas.0801523105.en_US
dc.identifier.citedreferenceCancer Research UK. 2012. Cancer incidence by age 2012. http://www.cancerresearchuk.org/cancer-info/cancerstats/incidence/age/ (accessedon 30 September 2012).en_US
dc.identifier.citedreferenceCaulin, A. F., and C. C. Maley. 2011. Peto's Paradox: evolution's prescription for cancer prevention. Trends in ecology & evolution 26: 175 – 182. doi: 10.1016/j.tree.2011.01.002.en_US
dc.identifier.citedreferenceCavallo, F., C. De Giovanni, P. Nanni, G. Forni, and P. L. Lollini 2011. The immune hallmarks of cancer. Cancer Immunology, Immunotherapy: CII 60: 319 – 326. doi: 10.1007/s00262‐010‐0968‐0.en_US
dc.identifier.citedreferenceChen, J., K. Sprouffske, Q. Huang, and C. C. Maley 2011. Solving the puzzle of metastasis: the evolution of cell migration in neoplasms. PLoS ONE 6: e17933. doi: 10.1371/journal.pone.0017933.en_US
dc.identifier.citedreferenceCoe, K., and L. Steadman. 1995. The human breast and the ancestral reproductive cycle. Human Nature 6: 197 – 220. doi: 10.1007/bf02734139.en_US
dc.identifier.citedreferenceColditz, G. A., B. A. Rosner, W. Y. Chen, M. D. Holmes, and S. E. Hankinson. 2004. Risk factors for breast cancer according to estrogen and progesterone receptor status. Journal of the National Cancer Institute 96: 218 – 228.en_US
dc.identifier.citedreferenceCooper, G. M., and R. E. Hausman 2009. The cell: a molecular approach. 4th ed. ASM Press, Sinauer Associates, Washington, D.C, Sunderland, Mass.en_US
dc.identifier.citedreferenceCorreia, A. L., and M. J. Bissell. 2012. The tumor microenvironment is a dominant force in multidrug resistance. Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy 15: 39 – 49. doi: 10.1016/j.drup.2012.01.006.en_US
dc.identifier.citedreferenceCoussens, L. M., and Z. Werb. 2002. Inflammation and cancer. Nature 420: 860 – 867. doi: 10.1038/nature01322.en_US
dc.identifier.citedreferenceCrespi, B., and K. Summers. 2005. Evolutionary biology of cancer. Trends in ecology & evolution 20: 545 – 552. doi: 10.1016/j.tree.2005.07.007.en_US
dc.identifier.citedreferenceDaoust, S. P., L. Fahrig, A. Martin, and F. Thomas. this issue. From forest and agro‐ecosystems to the microecosystems of the human body: what can landscape ecology tell us about tumor growth, metastasis and treatment options? Evolutionary Applications In this issue.en_US
dc.identifier.citedreferenceDavid, A. R., and M. R. Zimmerman. 2010. Cancer: an old disease, a new disease or something in between? Nature reviews. Cancer 10: 728 – 733. doi: 10.1038/nrc2914.en_US
dc.identifier.citedreferenceDawood, S. 2010. Triple‐negative breast cancer: epidemiology and management options. Drugs 70: 2247 – 2258. doi: 4 [pii] 10.2165/11538150‐000000000‐00000.en_US
dc.identifier.citedreferenceDe Stavola, B. L., I. dos Santos Silva, V. McCormack, R. J. Hardy, D. J. Kuh, and M. E. Wadsworth. 2004. Childhood growth and breast cancer. American journal of epidemiology 159: 671 – 682.en_US
dc.identifier.citedreferenceDolle, J. M., J. R. Daling, E. White, L. A. Brinton, D. R. Doody, P. L. Porter, and K. E. Malone. 2009. Risk factors for triple‐negative breast cancer in women under the age of 45 years. Cancer Epidemiology, Biomarkers & Prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 18: 1157 – 1166. doi: 1055‐9965.EPI‐08‐1005 [pii] 10.1158/1055‐9965.EPI‐08‐1005.en_US
dc.identifier.citedreferenceDyer, M. A., and R. Bremner. 2005. The search for the retinoblastoma cell of origin. Nature reviews. Cancer 5: 91 – 101. doi: 10.1038/nrc1545.en_US
dc.identifier.citedreferenceEaton, S. B., M. C. Pike, R. V. Short, N. C. Lee, J. Trussell, R. A. Hatcher, J. W. Wood et al., et al. 1994. Women's reproductive cancers in evolutionary context. The Quarterly review of biology 69: 353 – 367.en_US
dc.identifier.citedreferenceEckburg, P. B., E. M. Bik, C. N. Bernstein, E. Purdom, L. Dethlefsen, M. Sargent, S. R. Gill et al. 2005. Diversity of the human intestinal microbial flora. Science 308: 1635 – 1638. doi: 10.1126/science.1110591.en_US
dc.identifier.citedreferenceElias, S. G., P. H. Peeters, D. E. Grobbee, and P. A. van Noord. 2004. Breast cancer risk after caloric restriction during the 1944‐1945 Dutch famine. Journal of the National Cancer Institute 96: 539 – 546.en_US
dc.identifier.citedreferenceEwald, P. W., and H. A. Swain Ewald. this issue. Toward a general evolutionary theory of oncogenesis. Evolutionary Applications In this issue.en_US
dc.identifier.citedreferenceFernandez, A. A.. 2010. A cancer‐causing gene is positively correlated with male aggression in Xiphophorus cortezi. Journal of evolutionary biology 23: 386 – 396. doi: 10.1111/j.1420‐9101.2009.01914.x.en_US
dc.identifier.citedreferenceFisher, R. A. 1930. The genetical theory of natural selection. The Clarendon press: Oxford.en_US
dc.identifier.citedreferenceFoo, J., K. Leder, and M. Shannon. this issue. Cancer as a moving targe: Understanding the composition and rebound growth kinetics of recurrent tumors. Evolutionary Applications In this issue.en_US
dc.identifier.citedreferenceFoulkes, W. D., I. E. Smith, and J. S. Reis‐Filho. 2010. Triple‐negative breast cancer. New England Journal of Medicine 363: 1938 – 1948. doi: 10.1056/NEJMra1001389.en_US
dc.identifier.citedreferenceFrank, S. A. 2007a. Dynamics of Cancer: Incidence, Inheritance, and Evolution. Princeton University Press, Princeton (NJ).en_US
dc.identifier.citedreferenceFrank, S. A. 2007b. Dynamics of cancer: incidence, inheritance, and evolution, Princeton series in evolutionary biology. Princeton University Press, Princeton, N.J..en_US
dc.identifier.citedreferenceFrank, S. A.. 2010. Evolution in health and medicine Sackler colloquium: Somatic evolutionary genomics: mutations during development cause highly variable genetic mosaicism with risk of cancer and neurodegeneration. Proceedings of the National Academy of Sciences of the United States of America 107 ( Suppl 1 ): 1725 – 1730. doi: 10.1073/pnas.0909343106.en_US
dc.identifier.citedreferenceGabrilovich, D., and V. Pisarev. 2003. Tumor escape from immune response: mechanisms and targets of activity. Current drug targets 4: 525 – 536.en_US
dc.identifier.citedreferenceGarcia‐Cao, I., M. Garcia‐Cao, J. Martin‐Caballero, L. M. Criado, P. Klatt, J. M. Flores, J. C. Weill et al. 2002. “Super p53” mice exhibit enhanced DNA damage response, are tumor resistant and age normally. The EMBO Journal 21: 6225 – 6235.en_US
dc.identifier.citedreferenceGluckman, P., A. Beedle, and M. Hanson. 2009. Principles of Evolutionary Medicine. Oxford University Press, USA.en_US
dc.identifier.citedreferenceGatenby, R. A.. 2009. A change of strategy in the war on cancer. Nature 459: 508 – 509. doi: 10.1038/459508a.en_US
dc.identifier.citedreferenceGatenby, R. A., and R. J. Gillies. 2008. A microenvironmental model of carcinogenesis. Nature reviews. Cancer 8: 56 – 61. doi: 10.1038/nrc2255.en_US
dc.identifier.citedreferenceGatenby, R. A., A. S. Silva, R. J. Gillies, and B. R. Frieden. 2009. Adaptive therapy. Cancer research 69: 4894 – 4903. doi: 10.1158/0008‐5472.CAN‐08‐3658.en_US
dc.identifier.citedreferenceGatenby, R. A., R. J. Gillies, and J. S. Brown. 2010. Evolutionary dynamics of cancer prevention. Nature reviews. Cancer 10: 526 – 527.en_US
dc.identifier.citedreferenceGerlinger, M., A. J. Rowan, S. Horswell, J. Larkin, D. Endesfelder, E. Gronroos, P. Martinez et al. 2012. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. The New England journal of medicine 366: 883 – 892. doi: 10.1056/NEJMoa1113205.en_US
dc.identifier.citedreferenceGraham, T., R. Datta, A. Gutteridge, C. Swanton, and C. Maley. this issue. Modelling the evolution of genetic instability during tumour progression. Evolutionary Applications In this issue.en_US
dc.identifier.citedreferenceGreaves, M. this issue. Cancer stem cells as ‘units of selection’. Evolutionary Applications In this issue.en_US
dc.identifier.citedreferenceGreaves, M. F., and L. Kinlen. 2000. Cancer: the Evolutionary Legacy, Oxford University Press, Oxford.en_US
dc.identifier.citedreferenceGreaves, M. 2007. Darwinian medicine: a case for cancer. Nature reviews. Cancer 7: 213 – 221.en_US
dc.identifier.citedreferenceGreaves, M., and C. C. Maley. 2012. Clonal evolution in cancer. Nature 481: 306 – 313. doi: 10.1038/nature10762.en_US
dc.identifier.citedreferenceGrepin, R., and G. Pages. 2010. Molecular mechanisms of resistance to tumour anti‐angiogenic strategies. Journal of Oncology 2010: 835680. doi: 10.1155/2010/835680.en_US
dc.identifier.citedreferenceGrivennikov, S. I., F. R. Greten, and M. Karin. 2010. Immunity, inflammation, and cancer. Cell 140: 883 – 899. doi: 10.1016/j.cell.2010.01.025.en_US
dc.identifier.citedreferenceGuo, S., and L. A. Dipietro. 2010. Factors affecting wound healing. Journal of dental research 89: 219 – 229. doi: 10.1177/0022034509359125.en_US
dc.identifier.citedreferenceHanahan, D., and Weinberg, R. A.. 2000. The Hallmarks of Cancer. Cell 100: 57 – 70.en_US
dc.identifier.citedreferenceHansson, G. C.. 2012. Role of mucus layers in gut infection and inflammation. Current opinion in microbiology 15: 57 – 62. doi: 10.1016/j.mib.2011.11.002.en_US
dc.identifier.citedreferenceHardin, G. 1968. The Tragedy of the Commons. Science 162: 1243 – 1248.en_US
dc.identifier.citedreferenceHartwell, L. H., and M. B. Kastan. 1994. Cell cycle control and cancer. Science 266: 1821 – 1828.en_US
dc.identifier.citedreferenceHermes, G. L., and M. K. McClintock. 2008. Isolation and the timing of mammary gland development, gonadarche, and ovarian senescence: implications for mammary tumor burden. Developmental Psychobiology 50: 353 – 360. doi: 10.1002/dev.20295.en_US
dc.identifier.citedreferenceHochberg, M. E., F. Thomas, E. Assenat, and U. Hibner this issue. Preventive Evolutionary Medicine of Cancers. Evolutionary Applications In this issue.en_US
dc.identifier.citedreferenceHofman, P., and V. Vouret‐Craviari. 2012. Microbes‐induced EMT at the crossroad of inflammation and cancer. Gut Microbes 3: 176 – 185. doi: 10.4161/gmic.20288.en_US
dc.identifier.citedreferenceHsieh, C. C., D. Trichopoulos, K. Katsouyanni, and S. Yuasa. 1990. Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case‐control study. International Journal of Cancer. Journal International Du Cancer 46: 796 – 800.en_US
dc.identifier.citedreferenceJablonski, N. G.. 2004. The evolution of human skin and skin color. Annual Review of Anthropology 33: 585 – 623. doi: 10.1146/annurev.anthro.33.070203.143955.en_US
dc.identifier.citedreferenceJablonski, N. G., and G. Chaplin. 2010. Colloquium paper: human skin pigmentation as an adaptation to UV radiation. Proceedings of the National Academy of Sciences of the United States of America 107 ( Suppl 2 ): 8962 – 8968. doi: 10.1073/pnas.0914628107.en_US
dc.identifier.citedreferenceJasienska, G., and I. Thune. 2001. Lifestyle, hormones, and risk of breast cancer. BMJ 322: 586 – 587.en_US
dc.identifier.citedreferenceKareva, I. 2011. What can ecology teach us about cancer? Translational oncology 4: 266 – 270.en_US
dc.identifier.citedreferenceKeinan‐Boker, L., N. Vin‐Raviv, I. Liphshitz, S. Linn, and M. Barchana. 2009. Cancer incidence in Israeli Jewish survivors of World War II. Journal of the National Cancer Institute 101: 1489 – 1500. doi: djp327 [pii] 10.1093/jnci/djp327.en_US
dc.identifier.citedreferenceKoboldt, D. C., R. S. Fulton, M. D. McLellan, H. Schmidt, J. Kalicki‐Veizer, J. F. McMichael, L. L. Fulton, et al. 2012. Comprehensive molecular portraits of human breast tumours. Nature 490: 61 – 70.en_US
dc.identifier.citedreferenceKoupil, I., S. Plavinskaja, N. Parfenova, D. B. Shestov, P. D. Danziger, and D. Vagero. 2009. Cancer mortality in women and men who survived the siege of Leningrad (1941‐1944). International Journal of Cancer. Journal International Du Cancer 124: 1416 – 1421. doi: 10.1002/ijc.24093.en_US
dc.identifier.citedreferenceKruger, Daniel, and Randolph Nesse. 2006. An evolutionary life‐history framework for understanding sex differences in human mortality rates. Human nature 17: 74 – 97. doi: 10.1007/s12110‐006‐1021‐z.en_US
dc.identifier.citedreferenceLee, A. J., and C. Swanton. 2012. Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics. Biochemical pharmacology 83: 1013 – 1020. doi: 10.1016/j.bcp.2011.12.008.en_US
dc.identifier.citedreferenceLevine, D. S., C. E. Rubin, B. J. Reid, and R. C. Haggitt. 1989. Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study. Laboratory Investigation; A Journal of Technical Methods and Pathology 60: 418 – 432.en_US
dc.identifier.citedreferenceMaley, C. C., P. C. Galipeau, J. C. Finley, V. J. Wongsurawat, X. Li, C. A. Sanchez, T. G. Paulson et al. 2006. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nature genetics 38: 468 – 473. doi: 10.1038/ng1768.en_US
dc.identifier.citedreferenceMapara, M. Y., and M. Sykes. 2004. Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 22: 1136 – 1151. doi: 10.1200/JCO.2004.10.041.en_US
dc.identifier.citedreferenceMaynard Smith, J., and E., Szathmáry. 1995a. The major transitions in evolution. W.H. Freeman Spektrum, Oxford.en_US
dc.identifier.citedreferenceMaynard Smith, J., and E., Szathmáry. 1995b. The Major Transitions in Evolution. Oxford University Press, Oxford.en_US
dc.identifier.citedreferenceMelo, J. V., and D. J. Barnes. 2007. Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nature reviews. Cancer 7: 441 – 453. doi: 10.1038/nrc2147.en_US
dc.identifier.citedreferenceMerlo, L. M., and C. C. Maley. 2010. The role of genetic diversity in cancer. The Journal of clinical investigation 120: 401 – 403. doi: 10.1172/JCI42088.en_US
dc.identifier.citedreferenceMerlo, L. F., J. W. Pepper, B. J. Reid, and C. C. Maley. 2006. Cancer as an evolutionary and ecological process. Nature reviews Cancer 6: 924 – 935.en_US
dc.identifier.citedreferenceMerlo, L. M., N. A. Shah, X. Li, P. L. Blount, T. L. Vaughan, B. J. Reid, and C. C. Maley. 2010. A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma. Cancer prevention research 3: 1388 – 1397. doi: 10.1158/1940‐6207.CAPR‐10‐0108.en_US
dc.identifier.citedreferenceMeza, R., E. G. Luebeck, and S. H. Moolgavkar. 2005. Gestational mutations and carcinogenesis. Mathematical biosciences 197: 188 – 210. doi: 10.1016/j.mbs.2005.06.003.en_US
dc.identifier.citedreferenceNagy, J. A., A. M. Dvorak, and H. F. Dvorak. 2012. Vascular hyperpermeability, angiogenesis, and stroma generation. Cold Spring Harbor perspectives in medicine 2: a006544. doi: 10.1101/cshperspect.a006544.en_US
dc.identifier.citedreferenceNakasone, E. S., H. A. Askautrud, T. Kees, J. H. Park, V. Plaks, A. J. Ewald, M. Fein et al. 2012. Imaging tumor‐stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. Cancer Cell 21: 488 – 503. doi: 10.1016/j.ccr.2012.02.017.en_US
dc.identifier.citedreferenceNavin, N., J. Kendall, J. Troge, P. Andrews, L. Rodgers, J. McIndoo, K. Cook et al. 2011. Tumour evolution inferred by single‐cell sequencing. Nature 472: 90 – 94. doi: 10.1038/nature09807.en_US
dc.identifier.citedreferenceNedelcu, A. M.. 2009. Environmentally induced responses co‐opted for reproductive altruism. Biology letters 5: 805 – 808. doi: 10.1098/rsbl.2009.0334.en_US
dc.identifier.citedreferenceNerlich, A. G., H. Rohrbach, B. Bachmeier, and A. Zink. 2006. Malignant tumors in two ancient populations: An approach to historical tumor epidemiology. Oncology reports 16: 197 – 202.en_US
dc.identifier.citedreferenceNesse, R. M.. 2005. Maladaptation and natural selection. The Quarterly review of biology 80: 62 – 70.en_US
dc.identifier.citedreferenceNesse, R. M. and C. S. Stearns 2008. The great opportunity: evolutionary applications to medicine and public health. Evolutionary Applications 1: 28 – 48.en_US
dc.identifier.citedreferenceNesse, R. M., and G. C. Williams. 1994. Why we get sick: The new science of Darwinian medicine. 1st ed. Times Books: New York.en_US
dc.identifier.citedreferenceNik‐Zainal, S., P. Van Loo, D. C. Wedge, L. B. Alexandrov, C. D. Greenman, K. W. Lau, K. Raine, et al. 2012. The life history of 21 breast cancers. Cell 149: 994 – 1007. doi: 10.1016/j.cell.2012.04.023.en_US
dc.identifier.citedreferenceNunney, L. this issue. The real war on cancer: the evolutionary dynamics of cancer suppression. Evolutionary Applications In this issue.en_US
dc.identifier.citedreferencePark, S. Y., M. Gonen, H. J. Kim, F. Michor, and K. Polyak. 2010. Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. The Journal of clinical investigation 120: 636 – 644. doi: 10.1172/JCI40724.en_US
dc.identifier.citedreferencePepper, J. W.. 2012. Drugs that target pathogen public goods are robust against evolved drug resistance. Evolutionary Applications 5: 757 – 761.en_US
dc.identifier.citedreferencePepper, J. W., S. C. Findlay, R. Kassen, S. L. Spencer, and C. C. Maley. 2009. Cancer research meets evolutionary biology. Evolutionary Applications 2: 62 – 70.en_US
dc.identifier.citedreferencePeterson, J., S. Garges, M. Giovanni, P. McInnes, L. Wang, J. A. Schloss, V. Bonazzi, et al. 2009. The NIH Human Microbiome Project. Genome research 19: 2317 – 2323. doi: 10.1101/gr.096651.109.en_US
dc.identifier.citedreferencePeto, R., S. Darby, H. Deo, P. Silcocks, E. Whitley, and R. Doll. 2000. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case‐control studies. BMJ 321: 323 – 329.en_US
dc.identifier.citedreferencePienta, K. J., N. McGregor, R. Axelrod, and D. E. Axelrod. 2008. Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments. Translational Oncology 1: 158 – 164.en_US
dc.identifier.citedreferencePontiggia, O., R. Sampayo, D. Raffo, A. Motter, R. Xu, M. J. Bissell, E. B. Joffe et al. 2012. The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through beta1 integrin. Breast cancer research and treatment 133: 459 – 471. doi: 10.1007/s10549‐011‐1766‐x.en_US
dc.identifier.citedreferenceReiter, J. G., I. Bozic, B. Allen, K. Chatterjee, and M. A. Nowak this issue. The effect of one additional driver mutation on tumor progression. Evolutionary Applications In this issue.en_US
dc.identifier.citedreferenceRoche, B., K. Sprouffske, H. Hbid, D. Missé, M. Hochberg, and F. Thomas. this issue. Peto's paradox revisited: theoretical evolutionary dynamics of cancer in wildlife. Evolutionary Applications In this issue.en_US
dc.identifier.citedreferenceRogers, A. B.. 2011. Distance burning: how gut microbes promote extraintestinal cancers. Gut Microbes 2: 52 – 57. doi: 10.4161/gmic.2.1.14761.en_US
dc.identifier.citedreferenceSauer, L. A., R. T. Dauchy, D. E. Blask, J. A. Krause, L. K. Davidson, and E. M. Dauchy. 2005. Eicosapentaenoic acid suppresses cell proliferation in MCF‐7 human breast cancer xenografts in nude rats via a pertussis toxin‐sensitive signal transduction pathway. The Journal of Nutrition 135: 2124 – 2129.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.